0001209191-20-044367.txt : 20200731
0001209191-20-044367.hdr.sgml : 20200731
20200731210530
ACCESSION NUMBER: 0001209191-20-044367
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200317
FILED AS OF DATE: 20200731
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hsu Frank J.
CENTRAL INDEX KEY: 0001786723
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 201067601
MAIL ADDRESS:
STREET 1: C/O ONCTERNAL THERAPEUTICS, INC.
STREET 2: 3525 DEL MAR HEIGHTS ROAD #821
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-03-17
2020-03-18
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001786723
Hsu Frank J.
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Stock Option
3.33
2020-03-17
4
A
0
16280
0.00
A
2030-03-17
Common Stock
16280
16280
D
The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
Fully vested on grant date.
/s/ Hazel M. Aker, Attorney-in-fact
2020-07-31